Cough is a common symptom experienced by athletes, particularly after exercise. We performed a systematic review to assess the following in this population: (1) the main causes of acute and recurrent cough, either exercise-induced or not, (2) how cough is assessed, and (3) how cough is treated in this population. From the systematic review, suggestions for management were developed.
Summary of Suggestions 1. In adult and adolescent athletes ( ‡ 12 years of age) complaining of acute or recurrent cough, we suggest to initially evaluate for the most commonly reported causes of cough in this group such as asthma, exerciseinduced bronchoconstriction (EIB), respiratory tract infections (RTIs), upper airway cough syndrome (UACS) due to rhinosinus conditions, and environmental exposures related to the sport training environments (Ungraded, Consensus Based).
2. In adult and adolescent athletes ( ‡ 12 years of age) complaining of acute or recurrent cough, we suggest that pulmonary function tests, particularly bronchoprovocation challenges, and assessment of allergy to common airborne allergens be performed in the investigation of cough to identify common etiologies such as asthma and EIB, and to evaluate the effects of environmental exposures such as allergens, respiratory irritants, and pollutants (Grade 2B).
3. In adult and adolescent athletes ( ‡ 12 years of age) complaining of acute or recurrent cough, we suggest to proceed with a systematic investigation based on suspected cause(s) from initial clinical assessment, with specific attention to the athlete's particular sport and training environment and context (exercise related or not) in which cough occurs, to determine its etiology (Ungraded, Consensus Based).
4. In adult and adolescent athletes ( ‡ 12 years of age) complaining of cough, we suggest a treatment trial directed at the suspected causes of cough similarly to the general population, but taking into account the sport performed and training environment. The anti-doping regulations and potential side effects of medications that could interfere with training performances should be reviewed and considered when appropriate (Ungraded, Consensus Based).
Remarks: Anti-doping regulations are provided by the World Anti-Doping Agency (WADA) (https://www. wada-ama.org). The World Anti-Doping Code is a document that brings consistency to anti-doping rules, regulations, and policies worldwide. It is updated annually and the Prohibited List identifies the substances and methods prohibited to athletes in and out of competition. The Global Drug Reference Online (Global DRO) provides athletes and support personnel with information about the prohibited status of specific substances based on the current WADA Prohibited List. The Global DRO provides specific information on products sold in the United Kingdom, Canada, and the United States. The Global DRO is created through a partnership between UK Sport, the Canadian Centre for Ethics in Sport, and the US Anti-Doping Agency (http://www.globaldro.com).
5. In adult and adolescent athletes ( ‡ 12 years of age) complaining of acute and recurrent cough, we suggest that investigators perform randomized control trials to assess the effects of disease-specific and/or environment-specific (eg, cold-air-induced cough) treatments on cough because there are minimal data on how to optimally treat cough in these groups (Ungraded, Consensus Based).
Cough is a symptom frequently reported by athletes and even more so in those involved in endurance sports.
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Conditions known to be responsible for cough in the general population may also be responsible for cough in athletes. [10] [11] [12] However, in this population, cough may also be associated with the inherent characteristics of specific sports and their training environments. For example, exercise-induced cough is particularly prevalent in swimmers and winter-sports athletes. 13, 14 In winter athletes, cough following exercise was more frequently reported during winter (71%) than during summer (44%). 9 Regarding other sports, a prevalence of exercise-induced cough was reported in 14% of football ABBREVIATIONS: DRO = Drug Reference Online; EIB = exerciseinduced bronchoconstriction; EIVCD = exercise-induced vocal cord dysfunction; GERD = gastroesophageal reflux disease; RTI = respiratory tract infection; UACS = upper airway cough syndrome; WADA = World Anti-Doping Agency players. 15 In addition, the large ventilatory volumes required by intense exercise may increase lung penetration of allergens or pollutants and cause airway dehydration. 10, 12, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Airway rewarming may also possibly modulate airway responses.
As part of the global effort of the American College of Chest Physicians (CHEST) to develop guidelines for the management of cough, it was decided to fill a gap in the literature by developing a clinical practice guideline on how to assess and treat cough in athletes. To do so, we performed a systematic review of the available publications on this topic to search for evidence to make specific recommendations or suggestions about identification of the cause of cough as well as the assessment and treatment of cough in this population. It was suggested that evaluation and management of cough in athletes should take into account many specific characteristics and special considerations for athletes, such as daily training, training environment, doping regulations, and frequent traveling. As each cause of cough might have a specific treatment, accurate diagnosis is essential to avoid using unnecessary medication.
Methods

Search Strategy
Systematic review of the literature was performed. Studies published in PubMed, Scopus, and the Cochrane Library were identified using the following search terms: (cough OR exercise induced asthma OR rhinitis OR sinusitis OR laryngitis OR GERD OR gastro-esophageal reflux OR gastroesophageal reflux OR "chronic eosinophilic bronchitis" OR bronchoconstriction OR "environmental exposures" OR "vocal cord" OR "upper airway diseases" OR allergies) AND (athlete OR athletes OR skiers OR skiing OR swimmers OR swimming OR runners OR rowing OR marathon OR Olympic OR "competitive sports") were identified. The search was limited to articles in French and English; it began with the initiation of these databases and ended in April 2015.
Study Selection
Being aware that there were only a few clinical trials on cough in the athlete, we included all types of study designs in our list of articles to review. References of included studies were searched to identify additional relevant publications. The study characteristics and inclusion/exclusion criteria were selected from the patient problem or population, intervention, comparison, and outcome (PICO) elements for all key clinical questions 26 (Table 1) . To be included, studies had to meet the following criteria: subjects were described as athletes, adults and adolescents aged $ 12 years who complained of acute or recurrent cough, regardless of the duration and relationship to exercise. A subject was considered an athlete if he/she participated in an organized team or individual sport and took part in regular sport competitions against other athletes. Ideally, the sport had to require some form of systematic and usually intense training, regardless of the level of competition or number of training hours. 27 
Data Extraction and Quality Assessment
Two authors (L-P. B. and J. T.) independently analyzed the titles and content of the abstracts recovered to assess inclusion criteria. From the selected titles and abstracts, full reports about potentially relevant studies were obtained, and the authors independently assessed eligibility of the studies. Disagreements were discussed and resolved by consensus. A third author, R. S. I., was available to help resolve disagreements if necessary.
For randomized controlled trials, the reviewers independently assessed the risk of bias criteria using criteria in the Cochrane Reviews. The criteria used were random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias) to the study protocol, blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), and selective reporting (reporting bias). 28 Quality assessment of observational studies was also performed. 29 
Guideline Framework
Grading of recommendations/suggestions was made according to the Grading of Recommendations Assessment, Development and Evaluation framework as adopted by CHEST. 30 This framework separates the process of rating the quality of evidence from that of determining the strength of the recommendation. The quality of evidence was based on risk of bias, inconsistency, indirectness, reporting bias, and imprecision. 31 The quality of evidence (ie, the confidence in estimates) was rated as high (A), moderate (B), and low or very low (C). The strength of recommendation was determined based on the quality of evidence and the balance of benefits and harms, patients' values and preferences, and availability of resources. 32 Level 1 represented strong recommendations in which benefits or harms clearly outweighed the other. Level 2 represented a weak recommendation in which it was not clear that the benefits outweighed the harms (or vice versa), and new research could change the direction or strength of these recommendations.
Developing Recommendations/Suggestions
To be included in this guideline, a recommendation or suggestion had to be voted on by 75% of the eligible members of the entire Cough Expert Panel and achieve ratings of "strongly agree" or "agree" by 80% of the voting panelists. No cough panel member was excluded from voting.
Results
Of 1,283 references identified by our search string and screened, 60 articles were included in the analysis. The process of study selection is outlined in Figure 1 . Five articles reported cough prevalence, 46 articles reported causes of cough, three papers discussed cough assessment, and six papers were on the treatment of respiratory symptoms in athletes. Although there were five randomized clinical trials on the treatment of respiratory symptoms in athletes, only one specifically assessed cough. Although the systematic review revealed many records of causes of cough in athletes, very few specifically addressed how to evaluate or treat cough in the athlete. As data on cough in athletes were often hidden in a set of other data (respiratory symptoms), evidence tables were difficult to produce and were done only for cough treatment in athletes. In general, the studies were randomized placebo-controlled, double-blind trials, and four of six were considered to be at low risk of bias.
Key Clinical Question 1: In adult and adolescent athletes 12 years of age or older, what are the main causes of recurrent or acute cough?
Causes of Cough
Although there has been no formal study on the comparative prevalence of causes of cough in athletes, cough in the athlete was mainly associated with asthma and EIB in 15 reports. 1, 7, 8, 11, [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] Other associations were reported with airway dehydration and environmental exposures in six studies, [21] [22] [23] [24] 44, 45 RTIs in five studies, [46] [47] [48] [49] [50] UACS due to rhinosinus conditions in two studies, 13, 51 and exercise-induced vocal cord dysfunction (EIVCD) in two studies. 52, 53 Although it is very common in athletes, we found no study on the effects of GERD on cough in this population. Eleven manuscripts reported less common causes of cough: exercise-induced pulmonary edema including nonimmersion sports in two publications, 20, 54 immersion sports in five studies, [55] [56] [57] [58] [59] high-altitude pulmonary edema in one publication, 60 as well as pulmonary embolism in one report, 61 salt water aspiration syndrome in one study, 62 and passive smoking in one case. 63 No publication was found on heart conditions that induced cough in athletes.
Practice Recommendations/Suggestions 1. In adult and adolescent athletes ( ‡ 12 years of age) complaining of acute or recurrent cough, we suggest to initially evaluate for the most commonly reported causes of cough in this group such as asthma, exercise-induced bronchoconstriction (EIB), respiratory tract infections (RTIs), upper airway cough syndrome (UACS) due to rhinosinus conditions, and environmental exposures related to the sport training environments (Ungraded, Consensus Based).
Key Clinical Question 2:
In adult and adolescent athletes ($ 12 years of age), how is acute or recurrent cough usually evaluated?
Assessment of Cough
Although there were no systematic evaluations of cough specifically proposed for athletes, the publications suggested that a search for causes of cough in athletes should take into account the history and temporal relationships between cough and exercise, its sudden onset or recurrence, and the training environment.
One study evaluated the seasonal variability of cough reflex sensitivity to capsaicin in winter athletes. 9 The 444 Evidence-Based Medicine prevalence of cough within 1 hour after exercise was higher in athletes compared with nonathletes, and cough was reported more frequently during winter in athletes. However, cough was not associated with cough reflex hypersensitivity to capsaicin, bronchoconstriction, or airway inflammation. Although the Allergy Questionnaire for Athletes 64 can be used as a predictor of allergy in athletes, 65 self-reported respiratory symptom questionnaires have not been shown to be reliable predictors for the diagnosis of exercise-induced asthma and airway hyperresponsiveness. 5, 6, 66 Practice Recommendations/Suggestions 2. In adult and adolescent athletes ( ‡ 12 years of age) complaining of acute or recurrent cough, we suggest that pulmonary function tests, particularly bronchoprovocation challenges, and assessment of allergy to common airborne allergens be performed in the investigation of cough to identify common etiologies such as asthma and EIB, and to evaluate the effects of environmental exposures such as allergens, respiratory irritants, and pollutants (Grade 2B).
3. In adult and adolescent athletes ( ‡ 12 years of age) complaining of acute or recurrent cough, we suggest to proceed with a systematic investigation based on suspected cause(s) from initial clinical assessment, with specific attention to the athlete's particular sport and training environment and context (exercise related or not) in which cough occurs, to determine its etiology (Ungraded, Consensus Based). journal.publications.chestnet.org
Treatment of Cough
There were only six studies looking at the effect of treatments on cough in the athlete (Table 2) . Usually, treatment targeted the suspected or confirmed causes, but the effects of therapy were usually noted for the whole spectrum of respiratory symptoms and not only cough, or they were not specifically reported for cough. In these six studies, the effects of different treatments on respiratory symptoms were evaluated in 201 athletes, mostly young men (mean age, 20 years; 84% men).
Medications assessed included ipratropium, 67 albuterol, 68 ciclesonide, 69 montelukast, 70 and budesonide. 71 Compared with placebo, these drugs had modest or no effects on exercise-induced respiratory symptoms, including cough. Only a subgroup of crosscountry skiers experienced a decrease in cough frequency and perception of cough intensity following exercise with pretreatment with 80 mg of inhaled ipratropium. 67 Finally, in a randomized double-blind, placebo-controlled clinical trial, a daily supplement of 600 mg of vitamin C for 21 days was reported to lead to a reduction in the duration and incidence of symptoms of upper RTIs, including cough, before and following a 90-km run. 72 Practice Recommendations/Suggestions 4. In adult and adolescent athletes ( ‡ 12 years of age) complaining of cough, we suggest a treatment trial directed at the suspected causes of cough similarly to the general population, but taking into account the sport performed and training environment. The antidoping regulations and potential side effects of medications that could interfere with training performances should be reviewed and considered when appropriate (Ungraded, Consensus Based).
Remarks: Anti-doping regulations are provided by WADA. The World Anti-Doping Code is a document that brings consistency to anti-doping rules, regulations, and policies worldwide. It is updated annually and the Prohibited List identifies the substances and methods prohibited to athletes in and out of competition (see Table 3 ).
The Global DRO provides athletes and support personnel with information about the prohibited status of specific substances based on the current WADA Prohibited List. The Global DRO provides specific information on products sold in the United Kingdom, Canada, and the United States. The Global DRO is created through a partnership between UK Sport, the Canadian Centre for Ethics in Sport, and the US AntiDoping Agency.
In adult and adolescent athletes ( ‡ 12 years of age)
complaining of acute and recurrent cough, we suggest that investigators perform randomized control trials to assess the effects of disease-specific and/or environment-specific (eg, cold-air-induced cough) treatments on cough because there are minimal data on how to optimally treat cough in these groups (Ungraded, Consensus Based).
Discussion
There is a lack of evidence on the optimal management of cough in the athlete. Although we were able to find some observations about the main causes of cough in this population, there has been no systematic approach to its evaluation. Moreover, some causes of cough were not addressed in the publications screened. For example, despite its high prevalence in endurance athletes, ranging between 30% and 70%, no report looked at GERD and cough in this population. [73] [74] [75] As GERD is indeed recognized to be a frequent cause of cough in the general population, 76 there is a need to look at this potential cause of cough in the athlete.
As asthma, EIB, and environmental exposure were the most common conditions associated with persistent cough, we suggest that pulmonary function tests, particularly bronchoprovocation challenges, and assessment of allergy to common airborne allergens should be considered in the investigation of cough in athletes. Investigation should, however, be guided by the probable cause of cough as determined by the initial clinical assessment (see Table 4 ).
Strengths and Limitations
Even though cough is a very commonly reported respiratory symptom in athletes, our analysis of the literature stresses the paucity of data on cough in the athlete. The strengths of this analysis include the extensive review of > 1,200 publications obtained according to the key words selected, the methodology used to perform the analysis, and its review by the CHEST Expert Cough Panel.
Its limitations are associated with the lack of highquality studies, the variable definition of an athlete among reports (resulting in a relatively heterogeneous group of athletes), the lack of specific analysis of cough among other types of respiratory symptoms, and the variable outcomes chosen to assess cough response to Table 3 legend for expansion of other abbreviations.
a The use of this drug is conditional; maximum daily doses of salbutamol and formoterol permitted are 1,600 and 54 mg/d, respectively. A urinary concentration of salbutamol > 1,000 ng/mL or of formoterol > 40 ng/mL is considered by the WADA to be an adverse analytic finding unless the athlete proves the drug was used therapeutically. There will be a presumption that the substance was not taken by inhalation therapeutically, and the athlete will have the burden of demonstrating by means of a controlled pharmacokinetic study that the level found in the athlete's urine sample was the result of therapeutic inhaled use. b These drugs are prohibited during competition only. The use of pseudoephedrine in competition is conditional; a maximum daily dose of 240 mg/d is permitted. The urinary concentration of pseudoephedrine should not be > 150 mg/mL. Athletes must stop taking pseudoephedrine at least 24 hours before competition.
journal.publications.chestnet.org treatment. In addition, the number of patients enrolled in the studies was small.
Future Research
Many gaps in knowledge need to be addressed regarding cough in the athlete. They include the following:
Determination of the prevalence of specific causes of cough in athletes according to the type of sport Evaluation of the mechanisms underlying exerciseinduced cough in athletes Documenting the incidence of cough in exercise and bronchoprovocation challenges Determination of the optimal way to assess cough in the athlete Determination of the role of GERD as a cause of cough in the athlete Performance of randomized controlled trials to assess the effects of current treatment options for cough in the athlete in the presence or absence of an identifiable pathologic condition Performance of well-designed, high-quality studies to determine the benefits of therapies when specific causes of cough have been identified in the athlete, also taking into account the type of sport and environmental exposures
Conclusions
Cough appears to be a common symptom in the athlete, is often related to environmental exposures during training, and occurs predominantly following intense exercise. Clinical history and specific investigations should allow identification of the cause of cough and targeting of treatment. Because there is a lack of evidence about how to best investigate and manage cough in the athlete, current guidelines produced for the general population should be applied in the athlete, taking into account the training-specific context and anti-doping regulations.
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